By DAVID SHAYWITZ, MD Despite (some might say, because of) a raft of new biological methods, pharma R&D has struggled with its EROOM problem, the fact that the cost of successfully developing a new drug, including the cost of failures, has been relentlessly
Read More...
Read the complete post at http://thehealthcareblog.com/blog/2018/01/23/pharmas-big-data-problem/
Posted
Jan 23 2018, 06:30 PM
by
THCB